Additional Information

Overview
This two day multidisciplinary conference brought together 14 leaders in research and clinical care related to bone cancer and bone loss to review and assess current knowledge for several specific topics in the field, identify significant gaps in current knowledge, develop specific recommendations for advancing the field, and develop a position paper summarizing findings and recommendations.

Program Topics

• How pathophysiology and preclinical data are informing our understanding of metastasis prevention.
• Implications of recent clinical results for adjuvant bone-targeted therapies in metastasis prevention.
• Implications of recent clinical results for adjuvant bone-targeted therapies in cancer-associated bone loss prevention.
• Challenges in optimizing bone-targeted therapies and future research.

Program Directors
Robert E. Coleman, MD, FRCP, Professor of Medical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield, UK; Theresa A. Guise, MD, Professor of Medicine Indiana University School of Medicine, Indianapolis, IN; Allan Lipton, MD, Professor of Medicine and Oncology, Penn State University, Hershey, PA; and G. David Roodman, MD, PhD, VA Pittsburgh Healthcare System, Pittsburgh, PA. 

Position Paper
The position paper was published in Cancer Treatment Reviews [Coleman et al.  Metastasis and bone loss: Advancing treatment and prevention. Cancer Treat Rev. 2010 May 15.]  Click on Publication Summary link below to access the position paper.

CME Monograph
A CME monograph was also produced and the activity is available through February 2011.  Click on CME Activity link below to access the monograph.

Educational Grant Support
Supported by educational grants provided by Amgen, Inc. and Novartis Pharmaceuticals.

Sponsorship
CME sponsorship and program management provided by InforMEDical Communications, Inc.